COVID-19 in Italy: Comparison of CT Findings from Time Zero to the Delta Variant.

ABSTRACT: On 12 March 2020, the World Health Organization (WHO) declared the novel Coronavirus (CoV) disease a global Pandemic and an emerging risk. In order to understand patterns that are typical in COVID-19 pneumonia and track the evolution of the disease, the role of the chest computed tomography (CT) is pivotal. The impact of the illness as well as the efficiency of the therapy are also monitored carefully when performing this imaging exam. Coronaviruses, specifically CoV-2, as RNA viruses, have a tendency to frequently change their genome, giving the virus beneficial characteristics such as greater transmissibility, pathogenicity and the possibility to escape the previously acquired immunity. Therefore, genome evaluation became an extremely important routine practice worldwide. In particular,

SUBMITTER: Maggialetti N 

PROVIDER: S-EPMC9026540 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature